EZZ EZZ Life Science Holdings Limited

—Mkt Cap: —P/E: —

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, South-East Asia, and internationally. The company …

Key Statistics

Company
Market Cap—
Enterprise Value2.57M USD
Revenue (TTM)31.98M USD
Gross Profit34.36M USD
Net Income (TTM)4.65M USD
Revenue/Share0.98 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorConsumer Defensive
IndustryPersonal Care
ISINAU0000130569
Valuation
P/E (Trailing)—
P/E (Forward)1.24
PEG—
EV/EBITDA-0.57
EV/Revenue0.08
P/S0.31
P/B0.58
EPS (TTM)-0.10
EPS (Forward)0.24
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin74.35%
Oper. Margin-30.29%
EBITDA Margin-13.99%
Profit Margin10.06%
ROE23.96%
ROA19.82%
Growth
Revenue Growth-49.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.06M USD
CapEx (TTM)180.29K USD
FCF Margin-16.34%
FCF Yield—
Net Debt-7.19M USD
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.01
Current Ratio8.70
Quick Ratio5.80
Book Value/Sh0.52 AUD
Cash/Share0.23 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield12.12%
5Y Avg Yield1.66%
Payout Ratio65.25%
Ex-Div DateNov 24, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.47.07M
Float13.50M
Insiders74.09%
Institutions0.04%
Technical
SMA 500.4433 AUD
SMA 2000.8176 AUD
Beta1.14
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)26.22K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—